Immunoassays are used routinely in NBS as a first-tier screening protocol, therefore the multiplex immunoassay presents as a viable alternative or complement to the TREC assay in detecting SCID.Low cost rapid test (Immunoassay vs. DNA testing)For markets where DNA/TREC Assay testing equipment is not.....
[更多]
To date no other components condensed within MSNs have been used for remote heating and delivery of materials. The selectivity and non-invasiveness of this technique marks an improvement over current drug delivery systems particularly for in vivo applications. In terms of cancer cell treatments.....
[更多]
While in vivo studies have not confirmed which drugs will be most useful for which cancers, studies suggest the first targets may be solid tumors, particularly colon cancer. In general, any disease or condition characterized by hyperproliferative cell growth may benefit from this therapeutic approac.....
[更多]
Prostate cancer
[更多]
| |< <- | [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] | -> >| |
